Corrigendum to “Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina”
2024
Correction of RSV Prevention Strategies Study
publication
Author Information
Author(s): Guiñazú Gonzalo, Dvorkin Julia, Mahmud Sarwat, Baral Ranju, Pecenka Clint, Libster Romina, Clark Andrew, Caballero Mauricio T.
Primary Institution: Centro INFANT de Medicina Traslacional (CIMET), Escuela de Bio y Nanotecnología (EByN), Universidad Nacional de San Martín (UNSAM), Buenos Aires, Argentina
Conclusion
The correction clarifies that both RSV prevention strategies could prevent over 50% of RSV deaths in infants under 6 months.
Supporting Evidence
- Both RSV mAb and maternal RSV vaccine could prevent over 50% of RSV deaths in infants under 6 months.
- Corrections were made to the estimated impact of the prevention strategies.
Takeaway
The study corrected some mistakes about how well RSV vaccines can protect babies from dying.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website